Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Chang, NJ

Biau-Hung Chang, Basking Ridge, NJ US

Patent application numberDescriptionPublished
20110046338Copolyester polyols, prepolymers, and polyurethane elastomers formed therefrom and processes for making same - Polyurethane elastomers formed from prepolymers derived from copolyester polyols. The copolyester polyols have segments derived from one or more polyesters and caprolactone or polycaprolactone. The polyurethane elastomers have good hardness stability at temperatures ranging from 0° C. to 30° C. and preferably have good hydrolytic stability.02-24-2011

Charles Chang, Wayne, NJ US

Patent application numberDescriptionPublished
20080251096Cosmetic compact - A dual dispensing mode cosmetic compact for use with a cosmetic powder puff, cosmetic applicator sponge, or cosmetic brush, has a base member with an annular lip, a well to hold a cake of cosmetic material, and a closure lid receivable onto the base member. A scraper member located adjacent the well is engageable with the upper surface of the cosmetic cake. Finger-engageable structures adjacent to the well are turnable thereon, and there is a driving connection between the finger-engageable structures and the scraper member, which effects corresponding turning movement of the latter during turning of the finger-engageable structures. In one mode, the scraper member shaves off limited quantities of the upper surface of the cosmetic cake to produce controlled amounts of dust-like cosmetic powder particulates therefrom. In another mode, the scraper member is shifted by the user, to a second position remote from and outside of the annular lip. This second position fully exposes the upper surface of the cosmetic cake and enables direct access to the cake surface by a cosmetic powder puff, cosmetic applicator sponge, or cosmetic brush.10-16-2008
20090044826Cosmetic compact - A cosmetic compact providing a molded plastic base, a first cover and combined second cover and grip handle, all disposed over the base. The first cover is hinged to the base. The combined second cover and grip handle are selectively removable from the base, and carry an applicator device which when stored, is disposed between the first cover and base. The arrangement enables the user to quickly open the first cover and immediately remove and manipulate the combined second cover and grip handle, and attached applicator device, for application of cosmetic to the face or body. An especially neat, compact construction thereby is realized.02-19-2009
20100219188Aluminum container - An aluminum container for dispensing beverage, includes a can having a cylindrical side wall, and transverse top and bottom walls. A pull tab mechanism is provided on the top wall to effect opening of the container. The transverse top wall has an upstanding peripheral rim, with one or two interrupted wall portions, one of said portions forming a spout for pouring the contents, or drinking from the container directly. The other of the interrupted wall portions provides a clearance space for facilitating the insertion of the user's finger beneath the pull tab in readiness for opening the container. The bottom wall of the container is provided with a removable appliqué, which may contain printed text/pictorial information, or information in the nature of a store or manufacturer's product coupon.09-02-2010

Patent applications by Charles Chang, Wayne, NJ US

Ching H. Chang, Fanwood, NJ US

Patent application numberDescriptionPublished
20110046056APOA-1 PEPTIDE MIMETICS - The invention relates to peptide mimetics for treating disorders associated with hypercholesterolemia and cardio-vascular disease. In particular, the invention relates to peptides that mimic the activity of apolipoprotein A-I (Apo AI).02-24-2011

Daphne Chang, Montville, NJ US

Patent application numberDescriptionPublished
20110271574SYSTEM AND METHOD FOR WEAPON DISCHARGE INHIBITION - A firing inhibition system for a firearm includes an electromechanical actuator electrically connected to a dynamic grip recognition module including at least one sensor and a microcontroller, wherein the at least one sensor is located in a portion of a firearm operable to receive grip pressure from a user and wherein the at least one sensor is operable to transmit a signal to the microcontroller, wherein the microcontroller is operable to receive programming comprising grip pressure of an authorized user and is operable to interpret whether the grip pressure of the user matches the grip pressure of the authorized user, and to send a signal to the electromechanical actuator to actuate or to not actuate.11-10-2011

Dustin S. Chang, Mt. Laurel, NJ US

Patent application numberDescriptionPublished
20110277848Acoustical Fluid Control Mechanism - An acoustical fluid control mechanism and a method of controlling fluid flow of a working fluid with the acoustical fluid control mechanism are provided. The mechanism comprises a resonance chamber that defines a cavity. The resonance chamber has a port. The cavity is sealed from the ambient but for the port for enabling oscillatory flow of a working fluid into and out of the cavity upon exposure of the resonance chamber to an acoustic signal containing a tone at a frequency that is substantially similar to a particular resonance frequency of the resonance chamber. The mechanism further includes a rectifier for introducing directional bias to the oscillatory flow of the working fluid through the port. The rectifier has an inlet connected to the port and an outlet for transmitting the directional flow of the working fluid away from the cavity. The outlet is in fluid communication with the port of the resonance chamber at least during transmission of the directional flow of the working fluid therethrough.11-17-2011

Emily P. Chang, Edison, NJ US

Patent application numberDescriptionPublished
20120135080Core-Shell Magnetic Particles and Related Methods - The invention provides core-shell magnetic particles comprising a magnetic core and a functional shell, methods for making same, methods of separation using same, methods for using same, and devices comprising same. The particles and methods of the invention are useful for targeting and removing substances of interest that may be found in complex mixtures.05-31-2012

Fangzhe Chang, Edison, NJ US

Patent application numberDescriptionPublished
20100070805Method and Apparatus for Validating System Properties Exhibited in Execution Traces - The invention includes a method and apparatus for validating system properties exhibited in execution traces. In one embodiment, a method for testing a system under test (SUT) includes determining a system testing result for the SUT using at least one structured term generated by monitoring an execution trace of the SUT using at least one parameterized pattern. A test procedure is executed for the SUT. The test procedure has at least one parameterized pattern associated therewith. An execution trace generated during execution of the test procedure is parsed, where the execution trace includes unstructured information and the execution trace is parsed using the at least one parameterized pattern to identify at least one matching pattern. A system testing result for the SUT is determined using at least one structured term that is generated using the at least one matching pattern. In this manner, behavior of the system under test during the test procedure may be validated.03-18-2010
20100180280SYSTEM AND METHOD FOR BATCH RESOURCE ALLOCATION - A system for configuring resources in an environment for use by at least one process. In one embodiment, the system includes: (1) a process sorter configured to rank the at least one process based on numbers of resources that steps in the at least one process can use, (2) an optimizer coupled to the process sorter and configured to employ an optimization heuristic to accumulate feasible allocations of resources to the steps based on the ranking of the at least one process, (3) a resource sorter coupled to the optimizer and configured to rank the resources in a non-decreasing order based on numbers of the steps in which the resources can be used, the optimizer further configured to remove one of the resources from consideration based on the ranking of the resources until infeasibility occurs and (4) an environment configuration interface configured to allow the environment to be configured in accordance with remaining ones of the resources.07-15-2010
20120002884METHOD AND APPARATUS FOR MANAGING VIDEO CONTENT - Video files stored in a data store are managed by analyzing the semantic relationship of at least one associated descriptive tag of a given video file to tags associated with video files in the data store. The results of the analysis are used to select a set of video files from those stored in the data store. The content of the given video file is compared with the content of the selected set to determine the similarity of the content. The results of the determination may be used to update information concerning the similarity of video files in the data store, for example, to be used in providing results in response to a search query.01-05-2012

Han Chang, Princeton Junction, NJ US

Patent application numberDescriptionPublished
20090042226Identification and cloning of a full-length human CLNK-related gene, MIST (MAST cell immunoreceptor signal transducer) - The present invention describes a newly discovered full-length polynucleotide encoding an SH2 domain-containing adapter protein, called human MIST, cloned, isolated and identified from a human spleen cDNA library. Also described are the MIST polypeptide sequence, expression vectors, host cells, agonists, antagonists, antisense molecules, and antibodies related to the polynucleotide and/or polypeptide of the present invention. Novel splice variant forms of human MIST are provided. Methods for screening for modulators, particularly inhibitors, of the MIST protein and use of the human MIST polynucleotide and polypeptide for therapeutics and diagnostics are described.02-12-2009
20090215995B-7 related nucleic acids and polypeptides useful for immunomodulation - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.08-27-2009
20100125127B7-related nucleic acids and polypeptides useful for immunomodulation - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.05-20-2010
20100136575B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.06-03-2010
20110294162B-7 RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.12-01-2011

Patent applications by Han Chang, Princeton Junction, NJ US

Hyunseok Chang, Holmdel, NJ US

Patent application numberDescriptionPublished
20110202646POLICY CONTROLLED TRAFFIC OFFLOAD VIA CONTENT SMART-LOADING - An example method includes receiving at a user device a policy from a communication network node, and loading the user device with content data based on the policy. The policy specifies a rule set and a corresponding action to undertake in the event of a condition satisfying the rule set and may be received at the user device in response to connection of the user device to the network node. The policy received may be an updated policy, and may be based on network conditions. Example apparatuses and methods determine how (for example, what access technology and what times, to best deliver content given the particulars for a user and the device state of the user, using a rules set that can be dynamically updated without user intervention by network operators based on network management policies. Delivery includes upload, download and sideload of a user device.08-18-2011

Jeanne Chang, Madison, NJ US

Patent application numberDescriptionPublished
20090186794DETERGENT COMPOSITION COMPRISING A BLOCK COPOLYMER - The invention relates to a detergent composition, suitable for use in dish washing or laundry, comprising at least 15% of a detersive surfactant(s), and a block copolymer, selected from the group consisting of (block A)-(block B) diblock copolymers, (block A)-(block B)-(block A) triblock copolymers, and (block B)-(block A)-(block B) triblock copolymers, wherein block A and block B derive from alpha ethylenically unsaturated monomers, at least one block being water-soluble. The detergent compositions provide an increased cleaning, and/or a decreased redeposition of the fatty substances once they are removed from a substrate.07-23-2009

Patent applications by Jeanne Chang, Madison, NJ US

Kirk Chang, Morganville, NJ US

Patent application numberDescriptionPublished
20100011118Call admission control and preemption control over a secure tactical network - In a secure network where the network characteristics are not known, a call admission control algorithm and a preemption control algorithm based on a destination node informing the source node of the observed carried traffic are used to regulate the amount of traffic that needs to be preempted by the source. The amount of traffic that needs to be preempted is based on the carried traffic measured at the destination node. The traffic to be preempted is based on the priority of the traffic, where the lowest priority traffic is the first to be preempted until the amount of traffic preempted is sufficient to allow the remaining traffic to pass through the network without congestion.01-14-2010
20110211480Call Admission Control and Preemption Control Over a Secure Tactical Network - In a secure network where the network characteristics are not known, a call admission control algorithm and a preemption control algorithm based on a destination node informing the source node of the observed carried traffic are used to regulate the amount of traffic that needs to be preempted by the source. The amount of traffic that needs to be preempted is based on the carried traffic measured at the destination node. The traffic to be preempted is based on the priority of the traffic, where the lowest priority traffic is the first to be preempted until the amount of traffic preempted is sufficient to allow the remaining traffic to pass through the network without congestion.09-01-2011

Kirk K. Chang, Morganville, NJ US

Patent application numberDescriptionPublished
20100220629Estimating Available Bandwidth And Enhancing Narrow Link Bandwidth Estimations In Telecommunications Networks Using Existing User Traffic - Without using additional probing packets, estimates of the narrow link bandwidth and available bandwidth of a network path are computed based on existing traffic. The network can be of different types such as a wireless battlefield network context or a wired or wireless commercial network environment. “Fast packets”, i.e. those packets which do not experience any queuing delay in the network, are identified. Fast packets are identified to resolve end-to-end packet delay into its constituent components (deterministic, transmission and queuing delays), estimate path utilization and eliminate the uncertainty (false alarms) that causes the prior art method to lose its effectiveness. An estimation algorithm computes end-to-end transmission delay and end-to-end deterministic delay of fast packets traveling along a path in a network. Examples of deterministic delay include satellite propagation delays and clock effects. Then, based on the results of the fast packet identifying algorithm, two logic branches are followed. A first branch calculates utilization and a second branch calculates narrow link bandwidth. The narrow link bandwidth is determined from the packet pair dispersion. The available bandwidth is obtained from the narrow link bandwidth and the utilization. Estimation of available bandwidth for an end-to-end network path allows traffic sources to judiciously regulate the volume of application traffic injected into the network.09-02-2010

Lehua Chang, Rahway, NJ US

Patent application numberDescriptionPublished
20110028481HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.02-03-2011

Lehua Chang, Ramsey, NJ US

Patent application numberDescriptionPublished
20090253705HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.10-08-2009
20110028461HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.02-03-2011

Patent applications by Lehua Chang, Ramsey, NJ US

Linda Chang, Wayne, NJ US

Patent application numberDescriptionPublished
20100152185DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - The instant invention provides compounds of formula I which are 5-lipoxygenase activating protein inhibitors.06-17-2010

Linda L. Chang, Wayne, NJ US

Patent application numberDescriptionPublished
20090197883Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use - The instant invention provides compounds of Formula (I) which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.08-06-2009
20090258884Substituted amides - Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.10-15-2009
20090258885Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis - The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents.10-15-2009
20100317645SUBSTITUTED DIAZEPINE SULFONAMIDES AS BOMBESIN RECEPTOR SUBTYPE-1 MODULATORS - Certain novel substituted diazepine sulfonamides are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.12-16-2010
20110144056PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH - The present invention is directed to certain imidazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer disease, and Parkinson's disease06-16-2011

Patent applications by Linda L. Chang, Wayne, NJ US

Mun Kyung Chang, Westampton, NJ US

Patent application numberDescriptionPublished
20110061669Hand Rest Vacuum and Method - A hand rest vacuum and method is provided for the nail care industry. A body is configured to be supported by a desk between a client and a nail care technician. A cushioned hand rest pad is supported by the body. The body has a retractable nozzle on the technician side of the body. The nozzle is in fluid communication through an interior volume of the body to a body discharge location. Air is pulled through the nozzle opening and through the body interior volume by a vacuum source. The vacuum source may be located within the body interior volume or may be located separately from the body. The interior volume may incorporate a particulate filter, a carbon filter or a cyclone particulate matter separator.03-17-2011

Richard Yen-Hsiang Chang, Bloomfield, NJ US

Patent application numberDescriptionPublished
20090041170Dynamic phase alignment methods and apparatus - Dynamic phase alignment circuitry selects from among several, phase-distributed, candidate clock signals the one of those signals that is currently best for use in controlling the timing of sampling of a serial data signal to recover the data from that signal. The circuitry selects two phase-adjacent ones of the candidate clock signals that are currently the two best candidates for final selection. The circuitry makes a final selection of the generally better one of these two best candidates in a way that avoids unproductive switching back and forth between these two best candidates.02-12-2009

Robert Chang, Plainsboro, NJ US

Patent application numberDescriptionPublished
20100005103DISTRIBUTED APPLICATION MANAGEMENT SOFTWARE - A system and method is provided for remote administration and management of a computer network, by installation of distributed software agents in remote network components, such as software agents implemented using encapsulated reusable interfaces such as COM or CORBA interfaces. Remote network management is effected by communication with the distributed agents using a structured language-independent parsable text document, such as a markup language; e.g. XML.01-07-2010

Robert Chang, Cherry Hill, NJ US

Patent application numberDescriptionPublished
20110136162Compositions and Methods for Functionalized Patterning of Tissue Engineering Substrates Including Bioprinting Cell-Laden Constructs for Multicompartment Tissue Chambers - The present invention relates to microfluidic systems and methods for monitoring or detecting a change in a characteristic of an input substance. Specifically, the invention relates to a model for in vitro pharmacokinetic study and other pharmaceutical applications, as well as other uses including computing, sensing, filtration, detoxification, production of chemicals and biomolecules, testing cell/tissue behavior, toxicology, drug metabolism, drug screening, drug discovery, and implantation into a subject. The present invention also relates to systems and methods of a microplasm functionalized surface patterning of a substrate. The present invention represents an improvement over existing plasma systems used to modify the surface of a substrate, as the present invention creates surface patterning without the use of a mask, stamp or a chemical treatment.06-09-2011
20110177590Bioprinted Nanoparticles and Methods of Use - The present invention provides compositions and methods that combine the initial patterning capabilities of a direct cell printing system with the active patterning capabilities of magnetically labeled cells, such as cells labeled with superparamagnetic nanoparticles. The present invention allows for the biofabrication of a complex three-dimensional tissue scaffold comprising bioactive factors and magnetically labeled cells, which can be further manipulated after initial patterning, as well as monitored over time, and repositioned as desired, within the tissue engineering construct.07-21-2011

Robert C. Chang, Cherry Hill, NJ US

Patent application numberDescriptionPublished
20090263849Bioprinting Three-Dimensional Structure Onto Microscale Tissue Analog Devices for Pharmacokinetic Study and Other Uses - A microfluidic system for monitoring or detecting a change in a parameter of an input substance, which includes a microfluidic device having a tissue chamber and a tissue analog placed in the tissue chamber, wherein the tissue analog has a vessel structure mimicking naturally occurring vessel network incorporated in the tissue analog.10-22-2009

Shean-Guang Chang, Morris Plains, NJ US

Patent application numberDescriptionPublished
20090259715SYSTEM AND METHOD FOR CLIENT INTEROPERABILITY - Disclosed herein is a system and method for client interoperability. In one embodiment, a method for client interoperability comprises establishing a network connection between a client and a proxy. The client requests a connection factory from the proxy. The proxy then obtains the connection factory from an application server using a Java Naming and Directory Interface (JNDI). Using the connection factory, a connection to a connection host from the client is created. When the client sends a message, the proxy receives the message and routes the message to a destination server. Similarly, when the client receives a message, the proxy receives the message from a destination server and passes the message to the client. The client can be specifically configured to extend JMS operability to a desired language. In one embodiment the client is a .NET client.10-15-2009

Shen Y. Chang, Rockaway, NJ US

Patent application numberDescriptionPublished
20080243587Increasing Incremental Spend By A Consumer - A rewards program has been developed that increases incremental spend by a consumer while maximizing the profits to a transactional account company. In an embodiment, a predicted spend of a given consumer over a given time period is calculated. A spend threshold for the consumer is set based on the predicted spend over the given time period. An incremental spend reward offer is then customized for the consumer, where the offer maximizes profits resulting from the offer based on a calculation of consumer profits derived from campaign group responses. The customization may involve, for example, simulating a response of the given consumer to an offer having various combinations of incentive variables, with the customized offer including the combination of incentive variables that maximizes profits resulting from the offer in the simulation. The consumer is rewarded for spend above the spend threshold during the given time period.10-02-2008
20090254413Portfolio Modeling and Campaign Optimization - In an embodiment of the invention, historical data related to multiple members of a customer loyalty program is gathered. A set of loyalty behavior models is developed for an individual member of the loyalty program is developed based on the historical data. For each campaign in a plurality of marketing campaigns, at least one combination of offers is inserted into each loyalty behavior model to output a plurality of net profit scores for the individual member, wherein each combination of offers outputs a separate net profit score. For each campaign in the plurality of campaigns, a combination of offers having the highest net profit score for the campaign is selected. The campaign having the highest net profit score of the plurality of campaigns is selected, and marketing materials for the selected campaign and combination of offers is transmitted to the individual member.10-08-2009

Shing Yue Chang, Parsippany, NJ US

Patent application numberDescriptionPublished
20100040679Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage - Compositions useful for treating an individual with nicotine dependence comprising a combination of an α02-18-2010

Ti-Chiun Chang, Princeton Juction, NJ US

Patent application numberDescriptionPublished
20090080756Method and system for correcting butting artifacts in X-ray images - A method and system for correcting butting artifacts in x-ray images is disclosed. In order to correct a butting artifact in an x-ray image, a butting artifact region in the x-ray image is normalized. Multiple intensity shift estimators are calculated for each pixel of each line of the butting artifact. Confidence intervals are calculated for each intensity shift estimator. A multiple hypothesis hidden Markov model (MH-HMM) is formulated based on the intensity shift operators and confidence measures subject to a smoothness constraint, and the MH-HMM is solved to determine intensity shift values for each pixel. A corrected image is generated by adjusting the intensity of each pixel of the butting artifact based on the intensity shift value for that pixel.03-26-2009

Ti-Chiun Chang, Princeton Junction, NJ US

Patent application numberDescriptionPublished
20090116713Method and system for human vision model guided medical image quality assessment - A method and system for image quality assessment is disclosed. The image quality assessment method is a no-reference method for objectively assessing the quality of medical images. This method is guided by the human vision model in order to accurately reflect human perception. A region of interest (ROI) of medical image is divided into non-overlapping blocks of equal size. Each of the blocks is categorized as a smooth block, a texture block, or an edge block. A perceptual sharpness measure, which is weighted by local contrast, is calculated for each of the edge blocks. A perceptual noise level measure, which is weighted by background luminance, is calculated for each of the smooth blocks. A sharpness quality index is determined based on the perceptual sharpness measures of all of the edge blocks, and a noise level quality index is determined based on the perceptual noise level measures of all of the smooth blocks. An overall image quality index can be determined by using task specific machine learning of samples of annotated images. The image quality assessment method can be used in applications, such as video/image compression and storage in healthcare and homeland security, and band-width limited wireless communication.05-07-2009
20100092061SYSTEM AND METHOD FOR DECOMPOSED TEMPORAL FILTERING FOR X-RAY GUIDED INTERVENTION APPLICATION - A method for temporally filtering medical images during a fluoroscopy guided intervention procedure includes providing a mask image, a fluoroscopy intervention image acquired at a current time during a medical intervention procedure, forming a subtraction image by subtracting the mask image from the intervention image, calculating a motion image of a moving structure in the subtraction image, forming a residual image by subtracting the motion image from the subtraction image, temporally filtering the residual image with a filtered image from a previous time, and adding the motion image to the temporally filtered residual image.04-15-2010
20100142789METHOD FOR CORRECTING MOTION ARTIFACTS IN MAGNETIC RESONANCE IMAGES - For resonance image data of an imaged subject, a method that first detects and estimates the dominant motions of k-space data (i.e., the motion vectors) and then constructs a graphical model for each estimated motion vector. The segments of the k-space that are determined to be corrupted by motion are restored by minimizing the energy associated with the corresponding graphical model. Consequently, the MR image of the imaged subject becomes free of motion artifacts.06-10-2010
20110064285SYSTEM AND METHOD FOR MULTI-IMAGE BASED STENT VISIBILITY ENHANCEMENT - A method for enhancing stent visibility in digital medical images includes providing a time series of 2-dimensional (2D) images of a stent in a vessel, estimating motion of the stent in a subset of images of the time series of images, estimating motion of clutter in the subset of images, where clutter comprises anatomical structures other than the stent, estimating a clutter layer in the subset of images from the estimated clutter motion, estimating a stent layer in the subset of images from the clutter layer and the estimated clutter motion, and minimizing a functional of the estimated stent motion, the estimated stent layer, the estimated clutter motion, and the estimated clutter layer to in calculate a refined stent layer image, where the refined stent layer image has enhanced visibility of the stent.03-17-2011
20110103674MARKER DETECTION IN X-RAY IMAGES - A method for detecting markers within X-ray images includes applying directional filters to a sequence of X-ray image frames. Marker candidate pixels are determined based on the output of the directional filters. Candidate pixels are grouped into clusters and distances between each possible pair of clusters is determined and the most frequently occurring distance is considered an estimated distance between markers. A first marker is detected at the cluster that most closely resembles a marker based on certain criteria and a second marker is then detected at a cluster that is the estimated distance from the first marker. The pair of first and second marker detections is scored to determine detection quality. If the detected marker pair has an acceptable score then the detected marker pair is used.05-05-2011

Patent applications by Ti-Chiun Chang, Princeton Junction, NJ US

Timothy M. Chang, Montville, NJ US

Patent application numberDescriptionPublished
20100210942SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS OF BIOLOGICAL STRUCTURES - Ultrasound systems and methods for detecting features of biological tissue, including fracture detection in bone tumor detection are described. Systems and methods may employ low transient pulse technology. Methods employ detection and analysis of behavioral patterns of different signal parameters such as flight time, maximum amplitude, phase angle, and correlation as indicators of the depth of a fracture and may be used in quantitative ultrasound bone fracture detection. Flight time and frequency components may be employed in tumor detection methods.08-19-2010

Timothy N. Chang, Montville, NJ US

Patent application numberDescriptionPublished
20090253216Delivery and Sensing of Metered Amounts of Liquid Materials - A liquid delivery apparatus is provided for depositing liquid materials onto prescribed areas. The apparatus includes a sensing and delivery pin and a photo sensor. The apparatus is sized to deliver a droplet of liquid material to the surface of a target area without coming into contact with the target surface. The apparatus is also capable of drawing geometric features, such as lines and grids of liquid material. The photo sensor measures the intensity of light during a processing cycle. Measured reflected-light intensity can be compared in real-time to a reference curve which is based on test process cycles representing the light intensity expected when the process proceeds in the preferred fashion to produce a normal spot having an expected droplet size. The light intensity measurements can also be fitted with a mathematical function such as an asymmetric double sigmoidal curve.10-08-2009
20110271574SYSTEM AND METHOD FOR WEAPON DISCHARGE INHIBITION - A firing inhibition system for a firearm includes an electromechanical actuator electrically connected to a dynamic grip recognition module including at least one sensor and a microcontroller, wherein the at least one sensor is located in a portion of a firearm operable to receive grip pressure from a user and wherein the at least one sensor is operable to transmit a signal to the microcontroller, wherein the microcontroller is operable to receive programming comprising grip pressure of an authorized user and is operable to interpret whether the grip pressure of the user matches the grip pressure of the authorized user, and to send a signal to the electromechanical actuator to actuate or to not actuate.11-10-2011

Patent applications by Timothy N. Chang, Montville, NJ US

William R. Chang, Colonia, NJ US

Patent application numberDescriptionPublished
20090088710VOLUME LIMITING BODILY FLUID DRAINAGE SYSTEM - A system and method are disclosed for automatically limiting the drainage of a bodily fluid such as cerebrospinal fluid (CSF) from a patient into a collection chamber. The collection chamber includes a vent having an hydrophobic filter for the passage of air to facilitate the movement of CSF yet to maintain a closed system. The system includes a buoyant float hingedly connected with the top of the collection chamber in one embodiment. When fluid rises in the collection chamber to a predetermined volume, buoyant force raises the float and causes a seal plug mounted on top of the float to seal one of an inflow port or a vent port. The float is limited to pivoting movement in one plane and to a certain angle within that plane. The system and method avoid overdrainage of CSF from the patient and overfilling of the collection chamber.04-02-2009

Wonsuk Chang, Princeton, NJ US

Patent application numberDescriptionPublished
20100279973SYNTHESIS OF PURINE NUCLEOSIDES - A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof.11-04-2010
20100286083NUCLEOSIDE ANALOGS - A purified compound having activity against hepatitis C virus is disclosed.11-11-2010
20110257121PURINE NUCLEOSIDE PHOSPHORAMIDATE - Disclosed herein is a compound represented by formula 1 or its hydrate thereof in crystalline or crystal-like form.10-20-2011

Yuh-Jye Chang, Bridgewater, NJ US

Patent application numberDescriptionPublished
20120117563OVERLOAD CONTROL IN A CLOUD COMPUTING ENVIRONMENT - Provided is a method and devices for overload control in a cloud computing environment. The method includes receiving a first message from a network element associated with the cloud computing environment. The first message includes information associated with a target virtual machine and a list of sessions from the one or more sessions to move from the serving virtual machine to the target virtual machine. Associating one or more client addresses with an address associated with the target virtual machine based on the list of sessions. And, treating the target virtual machine as the serving virtual machine if processing sessions associated with the list of sessions.05-10-2012

Yu-Hwa Chang, West Windsor, NJ US

Patent application numberDescriptionPublished
20090107881METHODS FOR INCREASING CATALYST CONCENTRATION IN HEAVY OIL AND/OR COAL RESID HYDROCRACKER - Methods and systems for hydrocracking a heavy oil feedstock using, a colloidally or molecularly dispersed catalyst (e.g., molybdenum sulfide) which provide for concentration of the colloidally dispersed catalyst within the lower quality materials requiring additional hydrocracking. In addition to increased catalyst concentration, the inventive systems and methods provide increased reactor throughput, increased reaction rate, and of course higher conversion of asphaltenes and lower quality materials. Increased conversion levels of asphaltenes and lower quality materials also reduces equipment fouling, enables the reactor to process a wider range of lower quality feedstocks, and can lead to more efficient use of a supported catalyst if used in combination with the colloidal or molecular catalyst.04-30-2009
20120009094SYSTEMS FOR INCREASING CATALYST CONCENTRATION IN HEAVY OIL AND/OR COAL RESID HYDROCRACKER - Systems for hydrocracking a heavy oil feedstock employ a colloidally or molecularly dispersed catalyst (e.g., molybdenum sulfide) which provide for concentration of the colloidally dispersed catalyst within the lower quality materials requiring additional hydrocracking. In addition to increased catalyst concentration, the inventive systems and methods provide increased reactor throughput, increased reaction rate, and of course higher conversion of asphaltenes and lower quality materials. Increased conversion levels of asphaltenes and lower quality materials also reduces equipment fouling, enables the reactor to process a wider range of lower quality feedstocks, and can lead to more efficient use of a supported catalyst if used in combination with the colloidal or molecular catalyst.01-12-2012